TCM
ITCI
Tang Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-220,000
| Closed | -$29M | – | 220 |
|
|
2025
Q1 | $29M | Sell |
220,000
-80,000
| -27% | -$10.6M | 1.61% | 13 |
|
|
2024
Q4 | $25.1M | Hold |
300,000
| – | – | 1.66% | 14 |
|
|
2024
Q3 | $22M | Hold |
300,000
| – | – | 1.57% | 17 |
|
|
2024
Q2 | $20.5M | Buy |
300,000
+150,000
| +100% | +$10.3M | 2.09% | 12 |
|
|
2024
Q1 | $10.4M | Sell |
150,000
-70,000
| -32% | -$4.84M | 1.08% | 29 |
|
|
2023
Q4 | $15.8M | Sell |
220,000
-80,000
| -27% | -$5.73M | 1.46% | 18 |
|
|
2023
Q3 | $15.6M | Hold |
300,000
| – | – | 2.21% | 12 |
|
|
2023
Q2 | $19M | Hold |
300,000
| – | – | 2.8% | 10 |
|
|
2023
Q1 | $16.2M | Buy |
300,000
+60,000
| +25% | +$3.25M | 2.42% | 13 |
|
|
2022
Q4 | $12.7M | Sell |
240,000
-400,000
| -63% | -$21.2M | 1.85% | 17 |
|
|
2022
Q3 | $29.8M | Sell |
640,000
-60,000
| -9% | -$2.79M | 3.65% | 6 |
|
|
2022
Q2 | $40M | Hold |
700,000
| – | – | 6.06% | 5 |
|
|
2022
Q1 | $42.8M | Buy |
+700,000
| New | +$42.8M | 8.57% | 2 |
|
|
2020
Q2 | – | Sell |
-41,444
| Closed | -$637K | – | 26 |
|
|
2020
Q1 | $637K | Buy |
+41,444
| New | +$637K | 0.09% | 22 |
|